SIBN Stock Analysis: Buy, Sell, or Hold?
SIBN - SI-BONE, Inc. Common Stock
$14.16
-0.44 (-3.01%)
▼
5d:
+15.4%
30d:
+3.58%
90d:
-7.63%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Distribution
SIBN is up 9.0% this week, but smart money is buying puts. Top strike: $15 2026-06-18 with 4,000 OI. Put ratio: 93% View Scanner →
Strength: 8.8/10
Get Alerted When SIBN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SIBN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SIBN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SIBN is currently trading at $14.16, which is considered extended relative to its 30-day fair value range of $12.63 to $14.10.
Technical Outlook: Technically, SIBN is in a strong downtrend. Immediate support is located at $11.48, while resistance sits at $14.94. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: SIBN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.33 (+64.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SIBN is in a strong downtrend. Immediate support is located at $11.48, while resistance sits at $14.94. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: SIBN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $23.33 (+64.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$12.63 -
$14.10
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 64.8% below Wall St target ($23.33)
Trading Range Analysis
30-Day Trading Range
$12.63 -
$14.10
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.48
Resistance Level
$14.94
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-40.12
Wall Street Target
$23.33
(+64.8%)
Revenue Growth (YoY)
11.2%
Profit Margin
-8.1%
Share & Embed Analysis
Last updated: May 18, 2026 5:13 AM ET
Data refreshes hourly during market hours. Next update: 6:13 AM
Data refreshes hourly during market hours. Next update: 6:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SIBN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Anshul Maheshwari
SELL
3318 shares
2026-04-02
Michael A Pisetsky
SELL
1335 shares
2026-04-02
Michael A Pisetsky
SELL
1799 shares
2026-04-01
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
